CURE Pharmaceutical Holding Corp. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 1.445 million compared to USD 280,000 a year ago. Operating loss was USD 4.499 million compared to operating Income of USD 1.980 million a year ago. Net loss was USD 3.171 million compared to net income of USD 2.046 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to basic earnings per share from continuing operations of USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to diluted earnings per share from continuing operations of USD 0.04 a year ago.